MiNK Therapeutics to Present Updated Data from Phase 2 Study Testing AgenT-797 in Gastric Cancer at AACR IO Annual Meeting
MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the discovery, development, and ...
manilatimes5d
Conduit Pharmaceuticals Transitions to Phase II of Sarborg Collaboration to Support AI-Driven Drug Development
Conduit and Sarborg complete all milestones of Phase I of their AI-driven drug development collaboration, and commence transitioning to Phase II, which will focus on developing personalized software ...
Pliant Therapeutics Provides Update on BEACON-IPF, a Phase 2b/3 Trial in Patients with Idiopathic Pulmonary Fibrosis
Following DSMB recommendation, the Company has voluntarily paused enrollment and dosing in the BEACON-IPF Phase 2b trial and will monitor current ...
EurekAlert!1d
Endocrine Society awards Baxter Prize to innovator in endocrine cancer drug discovery
Donald Patrick McDonnell, Ph.D., has been awarded the Endocrine Society’s John D. Baxter Prize for Entrepreneurship for discovering hormone therapies for treating breast and prostate cancer, the ...
Pliant Therapeutics, Inc.: Pliant Therapeutics Provides Update on BEACON-IPF, a Phase 2b/3 Trial in Patients with Idiopathic Pulmonary Fibrosis
Following DSMB recommendation, the Company has voluntarily paused enrollment and dosing in the BEACON-IPF Phase 2b trial and will monitor current patients while data is reviewed SOUTH SAN FRANCISCO, ...
unite2d
From Keyword Search to OpenAI’s Deep Research: How AI is Redefining Knowledge Discovery
The way we seek and process information has experienced a significant transformation over the past few years. Advances in ...
manilatimes23d
Shuttle Pharma Reaches Milestone in Patient Enrollment for Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma
More information about the Phase 2 study (NCT06359379) can be found at www.clinicaltrials.gov. Founded in 2012 by faculty members of the Georgetown University Medical Center, Shuttle Pharma is a ...
Conduit Pharmaceuticals Completes Strategic Review with Sarborg to Map Revolutionizing Drug Development with Artificial Intelligence
Conduit is planning how to effectively integrate an advanced platform-driven approach powered by artificial intelligence and cybernetics to ...
Vietnam Investment Review on MSN1d
Lion TCR's Liocyx-M004 Receives FDA Clearance to Launch Global Multicenter Phase 2 Clinical Trial in HBV-Related Hepatocellular Carcinoma
Lion TCR announced that its mRNA-encoded T-cell receptor (TCR)-T cell therapy product Liocyx-M004 has received clearance from ...
Spotify6d
Julie Adam promoted to CEO of Universal Music Canada; Jeffrey Remedios appointed President, Strategic Development, for REPUBLIC Collective
More big news about Universal Music Group‘s leadership teams in North America: UMG has promoted Julie Adam to President and CEO of Universal Music Canada (UMC). Both appointments are effective ...